These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 5803102)

  • 21. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of acute intravascular hemolysis on coagulation and fibrinolysis.
    Riedler G; Frick PG; Straub PW
    Helv Med Acta; 1968 Jul; 34(3):205-16. PubMed ID: 5670599
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experience with the PPSB fraction in surgery].
    Frick U
    Zentralbl Chir; 1972 Feb; 97(5):150-3. PubMed ID: 5020589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the coagulation system during postoperative treatment with anticoagulants].
    Popov-Cenić S
    Med Klin; 1966 Dec; 61(49):1960-4. PubMed ID: 5973257
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood coagulation factors during epidemic hepatitis in children].
    Seiler G; Gröpl H
    Arch Kinderheilkd; 1969 Jul; 179(2):164-71. PubMed ID: 5802842
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of the bleeding tendency in uremia with cryoprecipitate.
    Maierhoter W; Adams MB; Kleinman JG; Roth DA
    N Engl J Med; 1981 Sep; 305(11):645. PubMed ID: 6790987
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical pharmacology of trienolones, a group of new anabolically actine aestrane-derivatives (4,9,11-oestratrien-17beta-ol-3-on)].
    Krüskemper HL; Morgner KD; Noell G
    Arzneimittelforschung; 1967 Apr; 17(4):449-54. PubMed ID: 5632439
    [No Abstract]   [Full Text] [Related]  

  • 28. [Severe coagulopathy caused by immunological inhibitors of factors, II, V, VII and X].
    Hartmann S; Hartmann G; Duckert F
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1392. PubMed ID: 4420163
    [No Abstract]   [Full Text] [Related]  

  • 29. [Some parameters of blood clotting in neoplastic diseases].
    Panecka A; Korolko A; Uchacz M; Pozarowski A; Geca C
    Pol Tyg Lek; 1971 May; 26(21):782-4. PubMed ID: 5560119
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
    Straub PW
    Acta Med Scand Suppl; 1971; 526():1-95. PubMed ID: 5292077
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behavior of blood coagulation factors under the effect of a new pyrazol derivative during prolonged anticoagulant therapy].
    Wolf H
    Arzneimittelforschung; 1970 Sep; 20(9):1252-8. PubMed ID: 4098759
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of polyvinyl pyrrolidone on plasma coagulation factors.
    Perkins HA; Rolfs MR; Thacher C; Richards V
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):667-70. PubMed ID: 5959001
    [No Abstract]   [Full Text] [Related]  

  • 34. [Various aspects of the pathogenesis of thrombophlebitis].
    Drevina AI; Grinshteĭn EIa
    Vestn Khir Im I I Grek; 1971 Oct; 107(10):67-70. PubMed ID: 5142241
    [No Abstract]   [Full Text] [Related]  

  • 35. [Behavior of some blood coagulation factors in acute icterogenic hepatitis].
    Ravazzoni L; Casini E; Provvidenza G
    G Mal Infett Parassit; 1966 Oct; 18(10):666-8. PubMed ID: 5997195
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes of the blood-pH and coagulation potential (author's transl)].
    Neef H; Richter M; Fischer U
    Anaesthesist; 1974 Mar; 23(3):158-61. PubMed ID: 4460739
    [No Abstract]   [Full Text] [Related]  

  • 37. [Virus infection and blood coagulation].
    Linder M; Gagel C
    Thromb Diath Haemorrh; 1968 Dec; 20(3):603-4. PubMed ID: 5710476
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinico-metabolic effects induced by the administration of concentrated liver extract in chronic uremia].
    Mioli V; Albertazzi A; Vangelista A
    Minerva Med; 1968 Sep; 59(75):3931-8. PubMed ID: 5684815
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
    Richter K; Klingenberg K; Reinecke D
    Z Gesamte Inn Med; 1968 Jan; 23(1):18-21. PubMed ID: 5662427
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood coagulation and serum lipids in pregnant rats following endotoxin injection--studies of the Sanarelli-Shwartzmann phenomenon].
    Obst R; Jannakopulos E; Urbaschek B; Huth K; Müller-Berghaus G
    Thromb Diath Haemorrh; 1971 Dec; 26(3):474-87. PubMed ID: 4947420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.